{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:34:11Z","timestamp":1792802051901,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Antibiotic-resistant pathogens cause over 35,000 preventable deaths in the United States every year, and multiple strategies could decrease morbidity and mortality. As antibiotic stewardship requirements are being deployed for the outpatient setting, community providers are facing systematic challenges in implementing stewardship programs. Given that the vast majority of antibiotics are prescribed in the outpatient setting, there are endless opportunities to make a smart and informed choice when prescribing and to move the needle on antibiotic stewardship. Antibiotic stewardship in the community, or \u201csmart prescribing\u201d as we suggest, should factor in antibiotic efficacy, safety, local resistance rates, and overall cost, in addition to patient-specific factors and disease presentation, to arrive at an appropriate therapy. Here, we discuss some of the challenges, such as patient\/parent pressure to prescribe, lack of data or resources for implementation, and a disconnect between guidelines and real-world practice, among others. We have assembled an easy-to-use best practice guide for providers in the outpatient setting who lack the time or resources to develop a plan or consult lengthy guidelines. We provide specific suggestions for antibiotic prescribing that align real-world clinical practice with best practices for antibiotic stewardship for two of the most common bacterial infections seen in the outpatient setting: community-acquired pneumonia and skin and soft-tissue infection. In addition, we discuss many ways that community providers, payors, and regulatory bodies can make antibiotic stewardship easier to implement and more streamlined in the outpatient setting.<\/jats:p>","DOI":"10.3389\/fmed.2022.901980","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T06:03:40Z","timestamp":1658901820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["It\u2019s about the patients: Practical antibiotic stewardship in outpatient settings in the United States"],"prefix":"10.3389","volume":"9","author":[{"given":"Alpesh N.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Patchen","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan D.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L.","family":"LaPlante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"LoVecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"McKinnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Tillotson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salisia","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"B1","year":"2019","journal-title":"Antibiotic Resistance Threats in the United States, 2019. US Department of Health and Human Services."},{"key":"B2","first-page":"200","article-title":"How to prescribe fewer unnecessary antibiotics: talking points that work.","volume":"94","author":"Fleming-Dutra","year":"2016","journal-title":"Am Fam Physician."},{"key":"B3","year":"2019","journal-title":"Outpatient Antibiotic Prescriptions \u2014 United States, 2019."},{"key":"B4","year":"2017","journal-title":"Antibiotic Prescription Fill Rates Declining in the U.S."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab412","article-title":"Non-visit-based and non-infection-related antibiotic use in the US: a cohort study of privately insured patients during 2016-2018.","volume":"8","author":"Fischer","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"B6","year":"2016","journal-title":"Antibiotic Use in Outpatient Settings."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1128\/AAC.02039-13","article-title":"Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments.","volume":"58","author":"Donnelly","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2020-001275","article-title":"Operationalising outpatient antimicrobial stewardship to reduce system-wide antibiotics for acute bronchitis.","volume":"10","author":"Johnson","year":"2021","journal-title":"BMJ Open Qual."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.amjmed.2013.08.016","article-title":"Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting.","volume":"126","author":"Hurley","year":"2013","journal-title":"Am J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.7326\/M20-7355","article-title":"Appropriate use of short-course antibiotics in common infections: best practice advice from the American College of Physicians.","volume":"174","author":"Lee","year":"2021","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1017\/ice.2020.1289","article-title":"Evaluation of antibiotic prescribing in emergency departments and urgent care centers across the veterans\u2019 health administration.","volume":"42","author":"Lowery","year":"2021","journal-title":"Infect Control Hosp Epidemiol."},{"key":"B12","first-page":"S30","article-title":"Adherence to antibiotic stewardship program associated with shorter course of treatment and fewer adverse events.","volume":"1","author":"Mulligan","year":"2021","journal-title":"Infect Control Hosp Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/jac\/dkab091","article-title":"Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.","volume":"76","author":"Slimings","year":"2021","journal-title":"J Antimicrob Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00337","DOI":"10.1128\/AAC.00337-18","article-title":"Prevalence of inappropriate antibiotic prescribing in primary care clinics within a veterans affairs health care system.","volume":"62","author":"Shivley","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1086\/678056","article-title":"Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.","volume":"35","author":"Jenkins","year":"2014","journal-title":"Infect Control Hosp Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American thoracic society and infectious diseases society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab063","article-title":"A multicenter evaluation of the US prevalence and regional variation in macrolide-resistant S. pneumoniae in ambulatory and hospitalized adult patients in the US.","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"B19","article-title":"Antibiotic susceptibility of Streptococcus pneumoniae in the US in 2014.","author":"Keedy","year":"","journal-title":"Poster at the MAD-ID Annual Meeting, Poster 2016."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.10.010","article-title":"Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program.","author":"Flamm","year":"2014","journal-title":"Poster at the Interscience Conference of Antimicrobial Agents and Chemotherapy Meeting, Poster C-554."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia.","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Prim."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa065","article-title":"Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: a real-world US insurance claims database study.","volume":"26","author":"Tillotson","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.673","article-title":"The microbiology laboratory is a valuable, but largely underutilized partner in antimicrobial stewardship and antimicrobial resistance monitoring.","volume":"1","author":"McKinnell","year":"2016","journal-title":"Open Forum Infect Dis."},{"key":"B24","year":"2020","journal-title":"Outpatient Antibiotic Prescribing Varied Across the United States in 2018: Fact Sheet."},{"key":"B25","year":"2020","journal-title":"English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Report 2019 to 2020, London, UK."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship.","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Morb Mort Wkly Rep."},{"key":"B27","year":"2021","journal-title":"Targeting Appropriate Prescribing in Outpatient Settings (TAP OUT). Los Angeles County Department of Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jcjq.2019.04.006","article-title":"Leading practices in antimicrobial stewardship: conference summary.","volume":"45","author":"Baker","year":"2019","journal-title":"Jt Comm J Qual Patient Saf."},{"key":"B29","year":"2019","journal-title":"R3 Report, Issue 23: Antimicrobial Stewardship in Ambulatory Health Care."},{"key":"B30","year":"2016","journal-title":"Toolkit 2: Monitor and Sustain Stewardship."},{"key":"B31","year":"2021","journal-title":"Antibiotic Stewardship Program."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/ofid\/ofab466.088","article-title":"Review of nursing home antibiotic stewardship citation deficiencies to identify opportunities to improve antibiotic stewardship implementation, 2018-2019.","volume":"8","author":"Gouin","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"B33","author":"McKinnell","year":"2019","journal-title":"Understanding Antimicrobial Stewardship (ASP) for Nursing Homes in California."},{"key":"B34","year":"2020","journal-title":"Survey of Doctors Reveals Challenges, Strategies for Reducing Inappropriate Antibiotic Use."},{"key":"B35","year":"2020","journal-title":"National Survey Reveals Barriers to Outpatient Antibiotic Stewardship Efforts."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B37","year":"2019","journal-title":"Core Elements of Hospital Antibiotic Stewardship Programs, US Department of Health and Human Services."},{"key":"B38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/sur.2020.436","article-title":"Surgical infection society 2020 updated guidelines on the management of complicated skin and soft tissue infections.","volume":"22","author":"Duane","year":"2021","journal-title":"Surg Infect."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1093\/jac\/dkw287","article-title":"Antimicrobial stewardship in wound care: a position paper from the British society for antimicrobial chemotherapy and European wound management association.","volume":"71","author":"Lipsky","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","article-title":"Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital.","volume":"48","author":"Pollack","year":"2015","journal-title":"J Emerg Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies.","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.7326\/M21-3034","article-title":"The future of medical guidelines: standardizing clinical care with the humility of uncertainty.","volume":"174","author":"Spellberg","year":"2021","journal-title":"Ann Intern Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1037\/hea0000456","article-title":"Expectations for antibiotics increase their prescribing: causal evidence about localized impact.","volume":"36","author":"Sirota","year":"2017","journal-title":"Health Psychol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/jac\/dky098","article-title":"Defensive medicine among antibiotic stewards: the international ESCMID AntibioLegalMap survey.","volume":"73","author":"Tebano","year":"2018","journal-title":"J Antimicrob Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/cid\/cix549","article-title":"Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus.","volume":"65","author":"Musher","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med."},{"key":"B48","article-title":"Demographics of culture positive patients in the admission period with skin and skin structure infection in the US: a multicenter evaluation of pathogen distribution.","author":"Cammarata","year":"","journal-title":"Poster at the 28th European Congress of Clinical Microbiology and Infectious Diseases, Poster E0285."},{"key":"B49","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1093\/cid\/ciz002","article-title":"Current epidemiology, etiology, and burden of acute skin infections in the United States.","volume":"68","author":"Kaye","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/QCO.0000000000000239","article-title":"Epidemiology and microbiology of skin and soft tissue infections.","volume":"29","author":"Esposito","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program.","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.mayocp.2014.04.018","article-title":"Hospitalist perspective on the treatment of skin and soft tissue infections.","volume":"89","author":"Amin","year":"2014","journal-title":"Mayo Clin Proc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1607033","article-title":"A placebo-controlled trial of antibiotics for smaller skin abscesses.","volume":"376","author":"Daum","year":"2017","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx188","article-title":"Guidelines vs actual management of skin and soft tissue infections in the emergency department.","volume":"5","author":"Kamath","year":"2018","journal-title":"Open Forum Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamadermatol.2019.0884","article-title":"Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis.","volume":"155","author":"Brindle","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab098","article-title":"Metrics for evaluating antibiotic use and prescribing in outpatient settings.","volume":"3","author":"Leung","year":"2021","journal-title":"JAC Antimicrob Resist."},{"key":"B57","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/acem.13690","article-title":"A multifaceted intervention improves prescribing for acute respiratory infection for adults and children in emergency department and urgent care settings.","volume":"26","author":"Yadav","year":"2019","journal-title":"Acad Emerg Med."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012739","article-title":"Prescriber preferences for behavioural economics interventions to improve treatment of acute respiratory infections: a discrete choice experiment.","volume":"6","author":"Gong","year":"2016","journal-title":"BMJ Open."},{"key":"B59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.mcna.2018.05.008","article-title":"Metrics of antimicrobial stewardship programs.","volume":"102","author":"Brotherton","year":"2018","journal-title":"Med Clin N Am."},{"key":"B60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.japh.2017.03.014","article-title":"Outpatient antibiotic stewardship: interventions and opportunities.","volume":"57","author":"Dobson","year":"2017","journal-title":"J Am Pharm Assoc."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.563","article-title":"The regional antibiogram is an important public health tool to improve empiric antibiotic selection, Stenotrophomonas maltophilia as a case example.","volume":"4","author":"Humphries","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cmi.2020.02.024","article-title":"Rapid diagnostic tests for infectious diseases in the emergency department.","volume":"27","author":"Bouzid","year":"2021","journal-title":"Clin Microbiol Infect."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114007","article-title":"Arriving at no: patient pressure to prescribe antibiotics and physicians\u2019 responses.","volume":"290","author":"Stivers","year":"2021","journal-title":"Soc Sci Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamainternmed.2013.14191","article-title":"Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial.","volume":"174","author":"Meeker","year":"2014","journal-title":"JAMA Intern Med."},{"key":"B65","year":"2021","journal-title":"Antibiotics Prescribing and Use: Patient Education and Promotional Resources."},{"key":"B66","year":"2021","journal-title":"Educational Resources for Healthcare Professionals."},{"key":"B67","year":"2022","journal-title":"Dialogue Around Respiratory Illness Treatment."},{"key":"B68","year":"2021","journal-title":"Antibiotic Stewardship Commendation."},{"key":"B69","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/ice.2019.51","article-title":"The role of electronic health record and \u201cadd-on\u201d clinical decision support systems to enhance antimicrobial stewardship programs.","volume":"40","author":"Kuper","year":"2019","journal-title":"Infect Control Hosp Epidemiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bmjqs-2021-013615","article-title":"Antibiotic overuse: managing uncertainty and mitigating against overtreatment.","volume":"31","author":"Tarrant","year":"2022","journal-title":"BMJ Qual Saf."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa174","article-title":"Utilizing behavioral science to improve antibiotic prescribing in rural urgent care settings.","volume":"7","author":"Cummings","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","article-title":"Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial.","volume":"315","author":"Meeker","year":"2016","journal-title":"JAMA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.amjmed.2008.10.043","article-title":"Exceptional mortality prediction by risk scores from common laboratory tests.","volume":"122","author":"Horne","year":"2009","journal-title":"Am J Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.amjmed.2005.01.00","article-title":"Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.","volume":"118","author":"Aujesky","year":"2005","journal-title":"Am J Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.mcna.2018.05.010","article-title":"The pharmacoeconomic aspects of antibiotic stewardship programs.","volume":"102","author":"Cunha","year":"2018","journal-title":"Med Clin North Am."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3111\/13696998.2015.1078339","article-title":"Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.","volume":"18","author":"Ektare","year":"2015","journal-title":"J Med Econ."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/jac\/dks194","article-title":"Antibiotic management and early discharge from hospital: an economic analysis.","volume":"67","author":"Gray","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2217\/fmb-2019-0227","article-title":"Combating resistance while maintaining innovation: the future of antimicrobial stewardship.","volume":"14","author":"Vickers","year":"2019","journal-title":"Future Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/cid\/ciy720","article-title":"Another new antibiotic for skin infections and why infectious disease specialists are hypocrites.","volume":"68","author":"Miller","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1021\/acsinfecdis.0c00044","article-title":"The antibacterial research and development pipeline needs urgent solutions.","volume":"6","author":"Beyer","year":"2020","journal-title":"ACS Infect Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.idc.2020.10.007","article-title":"Skin and soft tissue infections in patients with diabetes mellitus.","volume":"35","author":"Polk","year":"2021","journal-title":"Infect Dis Clin North Am."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1017\/ice.2019.276","article-title":"Research needs in antibiotic stewardship.","volume":"40","author":"Morris","year":"2019","journal-title":"Infect Control Hosp Epidemiol."},{"key":"B83","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2021.180","article-title":"The state of antibiotic stewardship programs in 2021: the perspective of an experienced steward.","volume":"1","author":"Barlam","year":"2021","journal-title":"Antimicrob Steward Health Epidemiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription.","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1185\/030079904125003304","article-title":"Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.","volume":"20","author":"Dunbar","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"B86","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial.","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jac\/dkn073","article-title":"Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.","volume":"61","author":"Asche","year":"2008","journal-title":"J Antimicrob Chemother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score.","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis.","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7\u201310 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B95","year":"2016","journal-title":"Consensus Document on the Management of Cellulitis in Lymphoedema."},{"key":"B96","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/acem.12727","article-title":"Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus.","volume":"22","author":"Jenkins","year":"2015","journal-title":"Acad Emerg Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs \u2013 six sites, 2005-2006.","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/ofid\/ofz360.1446","article-title":"Delafloxacin activity against drug-resistant Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, and Moraxella catarrhalis from US medical centers (2014-2018).","author":"Shortridge","year":"2019","journal-title":"Open Forum Infect Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.901980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T17:30:50Z","timestamp":1676223050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.901980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":98,"alternative-id":["10.3389\/fmed.2022.901980"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.901980","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"article-number":"901980"}}